Presentation
16 March 2023 Colorimetric detection of microRNA biomarkers using plasmonic nanoplatforms on a smartphone (Conference Presentation)
Author Affiliations +
Proceedings Volume PC12396, Plasmonics in Biology and Medicine XX; PC123960F (2023) https://doi.org/10.1117/12.2650585
Event: SPIE BiOS, 2023, San Francisco, California, United States
Abstract
MicroRNAs (miRNAs) are an emerging biotarget for clinical applications such as non-invasive detection of diseases such as cancer. However, current methods of miRNA quantification require tedious processing and amplification with highly trained specialists. Herein we show a simple and rapid colorimetric smartphone system that takes advantage of plasmonic nanoparticle-based assays to easily quantify miR-21 biomarker as a representative target for cancer disease detection. To achieve this, we use a unique assay known as Plasmonic Coupling Interference (PCI) to optically quantify the amount of biomarkers present. In addition, we utilize a specialized colorimetric processing method paired with accessible and cheap 3D printed parts to obviate the need for specialists to analyze and interpret the data. Our smart phone sensing system offers a practical miRNA diagnostic platform for the point-of-care applications as an alternative to more expensive lab-based methods.
Conference Presentation
© (2023) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Tushar Krishnan, Ren A. Odion, Hsin-Neng Wang, and Tuan Vo-Dinh "Colorimetric detection of microRNA biomarkers using plasmonic nanoplatforms on a smartphone (Conference Presentation)", Proc. SPIE PC12396, Plasmonics in Biology and Medicine XX, PC123960F (16 March 2023); https://doi.org/10.1117/12.2650585
Advertisement
Advertisement
KEYWORDS
Plasmonics

Cancer

3D acquisition

Diagnostics

Point-of-care devices

Sensing systems

Target detection

Back to Top